Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000127098 | SCV000170652 | benign | not specified | 2014-03-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000127098 | SCV000338386 | benign | not specified | 2016-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312907 | SCV000848020 | likely benign | Inborn genetic diseases | 2016-10-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000906946 | SCV001051617 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000906946 | SCV001501144 | likely benign | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing |